Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jan 19;19(1):e0297472. doi: 10.1371/journal.pone.0297472

Implementation of antimicrobial stewardship programs: A study of prescribers’ perspective of facilitators and barriers

Emelda E Chukwu 1,*, Dennis Abuh 1, Ifeoma E Idigbe 1, Kazeem A Osuolale 1, Vivian Chuka-Ebene 1,2, Oluwatoyin Awoderu 1, Rosemary A Audu 1, Folasade T Ogunsola 1,3
Editor: Mabel Kamweli Aworh4
PMCID: PMC10798493  PMID: 38241406

Abstract

Background

Despite promising signs of the benefits associated with Antimicrobial Stewardship Programs (ASPs), there remains limited knowledge on how to implement ASPs in peculiar settings for a more elaborate impact. This study explored prescriber experiences and perceptions of the usefulness, and feasibility of strategies employed for the implementation of antimicrobial stewardship (AMS) interventions as well as challenges encountered.

Methods

This is a cross-sectional mixed-method survey of prescribers’ perspective of the facilitators and barriers of implementing ASP. The quantitative approach comprised of a semi-structured questionnaire and data collected were analyzed using SPSS version 26 while the qualitative approach used focus group discussions followed by content analysis.

Results

Out of the thirty people that participated in the workshop, twenty-five completed the questionnaires which were analyzed. The respondents included 15 (60.0%) medical doctors and 10 (40.0%) pharmacists. The mean age of the respondents was 36.39±7.23 years with mean year of practice of 9.48±6.01 years. Majority of them (84.0%) were in a position to provide input on the implementation of AMS in their facilities, although their managements had the final decision. The pharmacists (100%) were more likely to agree that antibiotic resistance was a problem for their practice than the medical doctors (78.6%) while equal number (80.0%) of respondents (pharmacists and medical doctors) believed that inappropriate prescribing was a problem. Having a specialized and dedicated team with effective monitoring was recognized as crucial for effective ASP while inadequate personnel was identified as a major barrier. We identified stakeholder’s engagement, policies and regulation, as well as education as themes for improving AMS in the country.

Conclusion

The results gave insight into the prescribers’ perspective on the facilitators and barriers to antimicrobial stewardship; challenges and possible solutions to implementing ASPs in health facilities in Lagos State. We further identified pertinent contextual factors that need to be addressed when developing ASPs in healthcare facilities in a resource-poor setting.

Introduction

Antibiotic resistant bacteria cause infections that are difficult to treat and characteristically associated with increased morbidity, mortality, longer hospital stays, and excess health care costs [13]. Antibiotic use is a major driving force that selects for antibiotic resistant bacteria and approximately 50% of antibiotics used in hospitals have been estimated to be inappropriate [4]. The increasing global threat of antimicrobial resistance (AMR) has brought to the fore, the need for interventions to contain the emergence and transmission of AMR genes among bacteria pathogens. Antimicrobial stewardship programs (ASPs) have proven to be efficient in the short term, with no clear evidence of what the successful components are for a sustainable change in prescribing practices [5]. A systematic review of antimicrobial prescribing studies in hospitals suggests that sustainability of ASPs may be improved with a better understanding of behavioral determinants of prescribing [6]. Another review concluded that cultural, contextual and behavioral factors need to be addressed to influence antimicrobial use [7].

Antibiotic stewardship interventions are crucial to slow the development of resistance and it involves coordinated strategies designed to improve the appropriate use of antibiotics, by promoting the optimal drug, dose, duration, and route of administration [4]. Effective ASP will require multidisciplinary approach and engagement towards providing quality health care and ensuring patient safety. Despite the progress made on antibiotic stewardship in high income countries, most healthcare facilities especially in low- and middle-income countries still face barriers, such as limited financial and staff resources, in the implementation and maintenance of successful comprehensive antibiotic stewardship programs [8].

The global antimicrobial resistance and use surveillance system (GLASS) identified antimicrobial use (AMU) as a major driver of AMR and seeks to monitor AMU by collating the nationally aggregated data on antimicrobial consumption, as well as promoting studies on antibiotic prescription practices [9]. Nonetheless, generation of quality data that can inform national policy has continually proven to be a major challenge in most low- or middle-income countries (LMICs). Part of the key strategy of the Nigerian National Action Plan (NAP) to tackle AMR is to promote rational access to antibiotics and antimicrobial stewardship through optimizing of antimicrobial prescribing and dispensing in human and animals [10]. However, the extent to which the implementation of this 5-year strategic plan has been achieved remains to be ascertained. A recent evaluation of NAP implementation in WHO Africa region reveals the need for a context-driven approach, taking into account the specificities and peculiarities inherent in the respective member states [11].

The Center for Diseases Control and Prevention [CDC] has outlined core elements to improve antibiotic use in hospitals and nursing homes settings [12, 13]. Previous cross-sectional assessment revealed minimal ASP activities across healthcare facilities in Lagos State with sub-optimal performance in ASP implementing facilities [14]. However, it is not well understood which factors promote or hinder the implementation and maintenance of these programs within the Nigerian context. Both qualitative and quantitative studies have been carried out on this topic [1517], however, we explored the use of mixed-method to investigate facilitators and barriers to implementing AMS interventions as well as factors influencing antimicrobial prescribing practices among hospital doctors and pharmacists. This combined approach allows for the collection of numerical and measurable data while at the same time exploring the perspectives of the participants with a view to explain, validate or complement quantitative data. The objective of this study is to identify barriers and facilitators to antibiotic stewardship within selected (primary, secondary, tertiary and private/faith-based) healthcare facilities in Lagos State. This was achieved through qualitative interviews with medical doctors and pharmacists saddled with the responsibilities of making antibiotic recommendations within their facilities. This study aimed to identify facilitators, barriers and strategies in implementing AMS intervention in healthcare facilities in Lagos State and explored the potential role(s) of doctors and pharmacists in this intervention.

Methodology

Study setting

The study was carried out during a 3-day training workshop on Antimicrobial Stewardship for prescribers held at the Nigerian Institute of Medical Research (NIMR) from 15th to 17th November 2021. The workshop was titled “Improving antibiotic-related patient safety through proper antibiotic prescribing”. Facilities were selected to reflect the different categories of healthcare facilities in Lagos State i.e., the tertiary, secondary, primary and private/faith-based healthcare facilities, taking into account the number of different levels of healthcare facilities as classified by the National Strategic Health Development Plan [18] and identified in our previous needs assessment [14]. To ensure management buy-in and engagement in future implementation plans, the management of the selected facilities were asked to nominate key players in their AMS programs to participate in the training. The participants were medical doctors and pharmacists from selected healthcare facilities across Lagos State who have important roles in improving antibiotic use.

Study design and sampling technique

A cross-sectional descriptive mixed method study to investigate the prescriber’s perspective on the facilitators, barriers and strategies for implementation of ASP in healthcare facilities in Lagos State. The research design comprised both quantitative and qualitative methodologies. Quantitative data was collected through a semi-structured questionnaire to gather demographic information and assess the current level of ASP implementation in individual healthcare facilities. The questionnaire and interview guide for this study were developed by the study team from review of similar studies [19, 20], and can be found in the supplementary material (S1 Questionnaire and S1 File). The second phase involved a qualitative approach using focus group discussions followed by conventional content analysis. Purposeful sampling was used to recruit prescribers (doctors and pharmacists) attending the AMS training. All participants who attended the 3-day training on AMS and willingly provided their written consent were included in the questionnaire-based survey and/or focus group discussion. Qualitative data was collected using a semi-structured interview guide.

Focus Group Discussions (FGD)

FGD was conducted to obtain the views of medical doctors and pharmacists regarding the culture of antibiotic use at their healthcare facilities and on barriers and facilitators to antibiotic stewardship. Culture of antibiotic use was defined as the values, attitudes, and practices surrounding antibiotic use shared by the medical staff. Culture represents the way antibiotics are used and the attitudes of staff about how antibiotics are used. The interview questions and the analysis were guided by the framework used by Ploeg et al [21] to explore and understand individual (e.g., a clinician’s knowledge and attitudes), organizational (e.g., leadership support, teamwork), and environmental (e.g., support from national professional body) factors influencing inappropriate antibiotic use and antibiotic stewardship. Two sets of FGDs were conducted with 10 participants in each set. One set was conducted with medical doctors and another set was conducted with pharmacists. The FGDs had proper representation of participants based on demographics (Gender, age,) type of practice (public, private), range of experiences (early career, mid-career and advanced career clinicians and pharmacists) and the numbers of specialist in each group providing unique and vast knowledge.

Data analysis

Quantitative data was summarized using descriptive statistics and a significance level of P < 0.05 was considered statistically significant. The analysis of quantitative data was performed using SPSS version 26.0. For the qualitative approach, data were collected using Focus Group Discussion with consenting participants who attended the training on AMS.

All interviews were audio recorded and transcribed verbatim. Barrier and facilitator themes were identified from the transcripts and mapped using the COM-B (capability, opportunity, motivation and behavior) model [22]. Similarly, themes were identified from the transcripts regarding the roles of prescribers in AMS intervention. Employing the inductive approach, data were transcribed and coded using open coding to develop a codebook. The codebook included a list of question prompts, initial codes, and code meanings. The team developed a coding tree, deriving themes until reaching thematic saturation. Codes were reviewed, compared, analyzed, and sorted into categories to reflect consistent and overarching themes as described by Hsieh and Shannon [23].

Ethical clearance

Ethical clearance for this study was obtained from the Nigerian Institute of Medical Research Institutional Review Board (IRB/21/083). Participants were provided detailed written consent forms about the study and were informed of their rights to participate or decline in the study. Those who agreed to participate, signed a written consent form, and partook in the study. Information obtained from respondents were treated as confidential with no identifier.

Results

Quantitative study

Out of the thirty individuals who participated in the workshop, 26 (86.7%) consented and were included in the quantitative study. Twenty-six questionnaires were received but one was excluded due to incomplete filling (less than 50%). Therefore, a total of 25 questionnaires were analyzed with 15 (60%) being from medical doctors and 10 (40.0%) from pharmacists (Table 1).

Table 1. Demographics and practice characteristics of participants for quantitative study.

Variable Number (%)
Gender (N = 25)
Female 14 (56.0)
Male 11 (44.0)
Profession (N = 25)
Medical doctor 15 (60.0)
Pharmacist 10 (40)
Age groupsa (N = 23)
25–29 5 (20.0)
30–34 5 (20.0)
35–39 5 (20.0)
40–44 5 (20.0)
45 and above 3 (8.0)
Year of practice N = 25
1–5 9 (36.0)
6–10 4 (16.0)
11–15 9 (36.0)
16 and above 3 (12.0)
Healthcare category
Primary healthcare centres 3 (12.0)
Secondary Healthcare (General hospitals) 9 (36.0)
Tertiary healthcare (Teaching hospitals) 7 (28.0)
Private/ Faith-based hospitals 6 (24.0)
Does your facility have an antimicrobial stewardship team? b
Yes 12 (48.0)
No 10 (40.0)
I don’t know 2 (8.0)
Are you a member of your facility stewardship team? c
Yes 7 (28.0)
No 17 (68.0)

Key: a = missing 2, b = missing 1, c = missing 1

The participants’ mean age was 36.39±7.23 years with mean year of practice of 9.48±6.01 years. Among the respondents, the majority (84.0%) held positions that allowed them to provide input on the implementation of AMS in their respective healthcare facilities. However, the final decisions were made by their facilities’ management while one participant was a primary decision maker (Fig 1). About a half of the participants either did not have or were not sure if there existed an antimicrobial stewardship team in their facility while 28% were members of their facilities’ stewardship team (Table 1).

Fig 1. Response to the question on the level of authority to implement AMS in their facilities.

Fig 1

The participants gave varied responses to the question on the acceptability of stewardship approaches/ interventions (Fig 2). Over half (68.0%) of the respondents agreed that ASPs were needed in healthcare settings to effectively deal with antibiotic resistance, although a number of them (16.0%) were of the opinion that practice-based reporting would be too burdensome and 68.0% indicated that they would need a lot of help to implement antibiotics stewardship interventions. Majority (72.0%) of the respondents were confident that they prescribed antibiotics more appropriately than their peers while 36.0% believed that tracking the appropriate use of antibiotics would be difficult to do in an accurate and fair manner. The respondents (88.0%) reckoned that antibiotics stewardship efforts implemented by providers would be ineffective unless also paired with efforts aimed at educating patients/parents about antibiotic resistance and antibiotic use (Fig 2).

Fig 2. Responses to questions on the acceptability of stewardship approaches/ interventions.

Fig 2

Fig 3 depicted the responses of participants to questions on the perception of stewardship interventions. Although majority (96.0%) of the respondents believed that antibiotic resistance was a problem in Nigeria, only 84.0% agreed/strongly agreed that antibiotic resistance was a problem for their practice. All respondents agreed that inappropriate antibiotic prescribing in the outpatient healthcare setting accelerates the emergence of antibiotic resistance. However, 68.0% of the respondents held that the problem was not limited to outpatient healthcare setting (Fig 3).

Fig 3. Responses to questions on the perceptions of stewardship approaches/ interventions.

Fig 3

In general, 60.0% and 80.0% of the respondents believed that inappropriate antibiotic dispensing and prescribing was a problem in their practice respectively. However, when disaggregated between medical doctors and pharmacists, equal number (80.0%) of respondents (pharmacists and medical doctors) believed that inappropriate prescribing was a problem while pharmacists were less willing (40.0%) to agree that inappropriate dispensing was a problem for their practice (Fig 4). Nevertheless, the pharmacists (100%) were more likely to agree that antibiotic resistance is a problem for their practice than the medical doctors (78.6%).

Fig 4. Comparison of responses of the prescribers to some perception questions.

Fig 4

A = Antibiotic resistance is a problem for my practice. B = Inappropriate antibiotic prescribing is a problem in my practice. C = inappropriate antibiotic dispensing is a problem in my practice.

Qualitative study results/findings

A total of 20 respondents (Clinicians = 10; Pharmacists = 10) gave their consent and participated in the focus group discussion and were between the ages of 25 to 47 years. Two FGDs were conducted consisting of 10 participants each. Of these respondents, 12 were from government facilities and 8 were from private facilities. All participants resided and worked in Lagos State. Approximately, 70% of the respondents were females with average age of 36 years.

The respondents described the level of ASPs in their facilities which ranged from early-stage consultations to advanced level of ASP. Majority of the facilities were at the early stage of development with many of the facilities possessing a mini constituted team who were entrusted with the task of monitoring and controlling the use of antibiotics in patient management.

We don’t have an established antibiotics stewardship program. Yes, we don’t have but I know we had infection control committee at one time, that I was a member. I think we were about two pharmacists there. So…then, we were doing things to reduce the overall infection rate in the hospital. We were looking at the nosocomial infection rate. So, we are doing something on the side but just not as a committee” #Pharmacist 1

The antimicrobial stewardship is a small committee comprising of our medical directors, the health service manager, and pharmacists who work together to… you know… streamline the supply of drugs coming in and going out. But on a daily basis, the antimicrobial stewardship is headed by a consultant. We are trying to control the use of antibiotics amongst the medical team.” #Clinician 1

The department that does antimicrobial monitoring. That’s what we call it. And we do it basically for one patient or mainly for inpatient. So, we do it on a daily basis or on a weekly basis. We go through the antimicrobial chart of our patient”. #Clinician 2

However, one of the healthcare facilities had a stewardship program that had been running over a long period of time and were already implementing advanced AMS strategies.

We have Antimicrobial Stewardship Committee where we have Clinicians and there are nurses, there are clinical microbiologists from different departments, and we have been running for quite some time which I am a member of the committee. Then so much work has already been done by the stewardship committee. They have developed guideline for some departments- medicine. They’ve also developed antimicrobial use policy and they’ve done some prevalence surveys in the hospital. They’ve done some other studies and… So, the committee is very…very active”. #Clinician 3 (Public tertiary healthcare facility)

Facilitators to antimicrobial stewardship

Facilitators discussed by respondents that could promote AMS included creating specialized and dedicated team, having a data repository and effective monitoring.

Having specialized and dedicated teams. Some of the participants (n = 15) were of the opinion that ASPs should be created in health facilities and a team constituted with specialized professionals who would be passionate and dedicated to carry out tasks assigned to them in this regard. They believed that establishing teams in health facilities would make ASP easy to access and monitor while curtailing antibiotics misuse from the micro to the macro level.

But very importantly, we need to have dedicated personnel that will be facilitating this antibiotic stewardship. If you leave it open, everybody will just want to do his own thing. There will also be issues of…oh we are busy; we have other things we are doing ….” #Clinician 4

Then also, manpower is indeed useful…everybody has said that already. Manpower is very…very…useful. People are busy, so I think having a dedicated team can help with facilitating antimicrobial stewardship to make it even better.” #Pharmacist 2

Data repository. A few of the respondents (n = 4) were of the opinion that data on AMR should be captured in a local repository. They believed that having data on AMR would paint the true picture of the situation in the country and would help with baseline data for proper assessment as well as effectively implementing strategies to address salient issues related to antibiotic, its use and/or misuse. “So, we know that… some antibiotics are no longer effective for some infection anymore. But what are the data saying? Like the exact…trend in each antibiotic. Making that data available in a repository that is accessible to prescribers will go a long way and also be interesting to look at”. #Clinician 4

"Having accessible data that captures the true situation will give us a better picture to know the right steps to take” #Pharmacist 9

Monitoring. Most participants (n = 17) suggested monitoring as a strategy to assess ongoing activities, evaluate the level of progress made or setbacks recorded. Effective monitoring would ensure that tasks are conducted appropriately at the healthcare facility level, which would cascade to other facilities within the state and the country. Furthermore, monitoring will help curb illegal prescription, sanction perpetrators, reduce the abuse of antibiotics and AMR.

Antimicrobial stewardship has to be monitored just like we do in pharmacovigilance, and we need to start pushing it about the same way we are doing presently for pharmacovigilance. Such that it should become like a norm…it should become compulsory in all institutions”. #Pharmacist 7

Then, another aspect is… monitoring of the local pharmacy stores…… …particularly those patent medicine stores, the ones in the community. These people…they are not trained; they are not pharmacists…and they prescribe these antibiotics. So, I think they need to be constantly monitored through a monitoring team to curb illegal prescription”. #Pharmacist 1

Barriers to the uptake of stewardship programs

Respondents expressed genuine concern on the implementation of ASPs and might struggle with it due to certain perceived factors. Discussions on the barriers to AMS were summarized under five themes as follows.

Lack of data on AMR. Participants (n = 8) believed that there was paucity of data on AMR, which makes it difficult to access the true situation, address appropriately and proffer strategies to ameliorate future incidents from occurring. They proposed that health facilities should set up several databases that would capture activities regarding AMS and AMR with the goal to produce data to highlight stewardship activities and AMR profile, which could help in planning and executing programs. As expressed, “The truth is that we do not have facility-specific database to show the trend of AMR so it is difficult to make a case.” # Clinician 10

“We need data on antibiotic use to inform the hospital management about the prevalence…at least if we have data on the pattern of antibiotics consumption at the national, sub-national and facility level, then we can start from there to make a case”. #Pharmacist 1

Inadequate personnel. Majority of the respondents (n = 17) stated that there were a lot of untrained and unskilled personnel who prescribed antibiotics in the country, and little has been done to stop this. “We have a lot of unqualified people prescribing, and this is causing more harm in the society.” # Pharmacist 7. They believed that shortage of staff is also a major limitation to effective stewardship approach and if this trend continued, issues surrounding AMR would not be adequately addressed and this would worsen the situation in the country. “That’s what I mean because most practices are so busy…there is shortage of staff. So, nobody wants to take responsibility. If this kind of meetings can be brought closer to the facility with involvement of facility management, then they are more aware and then, maybe…can sit down with their antimicrobial stewardship teams and discuss the way forward”. #Pharmacist 10

Legislation and policies. Sixteen respondents believed that there were inadequate legislation and policies to guide AMS in the country. They advocated for key stakeholders to be involved in planning, decision-making, and implementation at various spheres at healthcare facilities, pharmacies, state and national level to ensure that the right activities were conducted, and standards were maintained. In addition, policies should be put in place to regulate activities, sanction perpetrators and drive strategies for effective and sustainable implementation and management.

There is always so much we can do through education. Education is important, I agree with you. But make laws first. If we don’t make laws, we can never get ahead in these things. The truth is that anybody can get any antibiotics they want over the counter, and we are still talking about this. I think we must be stricter with our policies”. #Pharmacist 5

I think we should take it up from…the government… from the top, policy formulation, augmentation of those policies. Then down to the……end-users of these drugs. The government needs to strengthen existing policies and regulations on the registration of companies involved in drug importation to curb the importation of sub-standard drugs and sanction offending companies”.# Clinician 1

Lack of focal persons engagement and teamwork. Participants (n = 16) stated that the managements at the different health facilities, state and federal government have not engaged the right professionals which has had rippling effects and consequences. They believe that the right staff/professionals should be employed or deployed to teams and departments that focused on AMS. They believed that by so doing, the appropriate personnel would have been trained and would possess the requisite skills. Furthermore, it would be easier to orientate and train them based on their educational background and professional expertise. “The management at the different health facilities need to ensure that they employ staff and constitute a dedicated team that will be trained as focal persons” # Pharmacist 1. The respondents also identified lack of critical collaboration and teamwork among key stakeholders as a major barrier and maintained that having dedicated staff working in teams will make the program effective.

We need to work as a team whether we like it or not. All stakeholders should be represented in the committee in the right proportion. And people that are in the committee should be able to work as a team irrespective of …. if you are a pharmacist or a doctor. It should not be a case of …… why a pharmacist would tell me a consultant what to do, . why should I do this? So, that’s why I said the willpower will have to be there and everybody should be willing to target the success of the program…. #Clinician 10

Extreme multitasking. Thirteen respondents stated that due to limited personnel who are overburdened with a lot of tasks at the healthcare facilities, it would be difficult to invest their attention on AMS. As expressed, “In the facility, we are overwhelmed with a lot of work, and it is difficult to combine all the activities effectively…it is the same people doing the same job. Clinician 10. “The problem with these committees is that most of these people are doing many other things. And then you want them to get involved with antimicrobial stewardship program” #Clinician 4. They proposed employing more staff to reduce the burden of work, create comfortable and conducive environments so that more attention can be paid to antimicrobial stewardship.

The management should…consider employing more qualified personnel to ensure that workload is evenly distributed and…. maybe less burdensome to engage in antimicrobial stewardship” #Pharmacist 3

Illustrative themes that highlight recommended strategies to improve antimicrobial stewardship. Discussions on the recommendations for effective ASPs identified stakeholder’s engagement, policies, and regulation; and education as themes for improving stewardship in the country.

The identified themes and sub-themes have been summarized in Table 2.

Table 2. Major themes and sub-themes for improving antimicrobial stewardship and representative quotes.
Themes Description of themes Sub-themes Representative quotes
Stakeholders Engagement Fourteen participants from the FGDs advocated for stakeholders’ engagement as a strategy for improving AMR stewardship in Nigeria. Stakeholders’ engagement was described as involving, advocating and imbibing all key players ranging from policy makers, regulators, healthcare providers, manufacturers, distributors and end-users in appropriate usage, prescribing, selling and consuming of antibiotics. This strategy was recommended because they believed that if stakeholders were educated, awareness will be created. Thus, they would be predisposed to appropriate practices at all healthcare facilities and pharmacies. Creating awareness "There is a need to inform and train people about using antibiotics properly so that they can get the knowledge" #Clinician 2
“I’m talking about schools,.. let’s embed antimicrobial stewardship in our curriculums even as early as primary school. At the primary school level, they already teach them about drug abuse, drug misuse. So, this can be expanded upon to teach them about antimicrobial use, misuse and abuse”. #Pharmacist 6
Resources/Manpower “It is important to have dedicated team/ personnel that would be mostly involved in antimicrobial stewardship “#Clinician 1
"Antimicrobial stewardship should be made as a career path for undergraduates and hospitals should employ people whose job is to focus on antibiotics use in the hospital to provide expertise #Pharmacist 10
Policies and Regulation Nineteen participants believed that if rules were set up and guided by strict regulatory bodies, improper use of antibiotics would be significantly reduced in the country. Regulations are rules, processes or directives made and maintained by an authority to oversee activities. Participants proposed that regulatory bodies should be put in place to monitor activities. Regulatory roles “Rules and laws should be enacted to guide the distribution and prescription of antibiotics by professionals. Also there should be periodic supervision to health facilities and pharmacies where antibiotics is prescribed “# Pharmacist 7
“There should be regulatory teams set up to monitor Antimicrobial stewardship activities at different levels in the country“# Clinician 6
Sanctions “There should be punishments for violators which will serve as an example for others to obey “# Clinician 5
“People who are not trained but are prescribing antibiotics should be identified and sanctioned “# Pharmacist 8
Education and training Nineteen participants believed that education and training was key to achieving AMS and this should involve the key stakeholders and not just a few persons but including doctors, nurses, pharmacists and the management team to ensure an impactful outcome. The participants believed that creating awareness about antibiotics, its use and abuse would help educate, not just prescribers but also facilitate knowledge among end-users thus helping them take the right steps to make proper health decisions. If end-users are educated, they would seek appropriate channels to access health facilities and would take antibiotics only when prescribed by a physician. Role Training professionals/Specialized staff “Clinicians/practitioners need to train themselves and have the right mentality so as to have a good knowledge of antibiotic resistance” # Clinician 4
“Meetings and trainings concerning Antimicrobial stewardship should be conducted frequently within facilities or made accessible so that it reaches the right professionals “# Pharmacist 3
Educating End-users “Awareness should be created using mass media platforms so that end-users know the dangers of abusing antibiotics “#Pharmacist 3
“I work in the Internal Medicine department, and I believe educating the patient too is important…if we have…. probably someone who is trained in antimicrobial stewardship to educate patients at least in the hospital out-patient, we have quite a lot of patients we can find in all these public hospitals. So, by the time we do that, I believe we can virtually educate a lot of people outside there…not just the clinicians alone… if we can educate a lot of people then we are closer to winning this war…at least getting somewhere that we are pushing” #Clinician 4
“Patients should be taught to go to registered hospitals to access healthcare so that if needed, antibiotics would be prescribed by the specialist “#Clinician 6

Discussion

Antimicrobial stewardship has garnered attention recently as a major means of optimizing antimicrobial use and mitigating AMR. This study identified contextual factors that can mitigate successful implementation of AMS in healthcare facilities in Lagos State. Several hospitals are still facing challenges in the implementation of ASPs despite efforts by CDC in outlining core elements to facilitate implementation of AMS in healthcare setting [12]. Our respondents described various levels of AMS in their facilities with only one facility [tertiary hospital] describing a well-structured and functional stewardship program as recommended by CDC [12]. However, many of the respondents were confident that they can provide input on the implementation of AMS at the facility level although final decision-making still lies in the hands of the facility management. This is consistent with a previous report which revealed minimal ASP activities in healthcare facilities in Lagos State with sub-optimal performance in implementing facilities [14].

Appropriate antimicrobial use has been linked to improved patient outcomes and decreased risk of adverse events, including development of AMR [24]. Although majority of the respondents agreed that ASPs are needed in healthcare settings to effectively deal with AMR, lack of data on AMR was identified as a major obstacle to the uptake of ASP. Availability of cohesive data on AMR has been the bane of most resource poor countries with available data fragmented and lacking in representativeness [25]. Current efforts are being made to collect and collate AMR surveillance data via the GLASS program following the implementation of the Nigerian national action plan for AMR [9, 10]. However, a lot more still needs to be done to decentralize data and include grass root healthcare facilities in the surveillance. Prescribers undoubtedly require data on AMR to be able to fully assess situations and make rational judgements to guide treatment and practice and these data need to be continually updated to reflect current reality. The respondents advocated for facility-specific databases tasked with aggregating AMR data, as a practical approach to solving the problem of dearth of data especially in the Nigerian context.

There were varied perspective among respondents on the problem of AMR with the pharmacists more likely to acknowledge that AMR was a problem for their practice than the medical doctors. This result is consistent with a survey of primary care physicians’ attitude and perception towards AMS where only 55% of the physicians agreed that antibiotic resistance was a problem in their practice [19]. This inability to take personal responsibility poses a great challenge to the success of ASP. Some of the clinicians believed that AMR is a problem majorly emanating from unqualified practitioners who are prescribing antibiotics without adequate training. Nevertheless, both professionals jointly agreed that inappropriate prescribing of antibiotics is a major driver of AMR and a problem in their practice (See Fig 4).

Facilitators suggested by participants that could promote AMS included creating specialized and dedicated team, effective monitoring, and establishment of data repository. Some of these factors differ slightly from what has been reported elsewhere [8, 20, 26], indicating contextual undertone. A study on the perspective of pharmacists identified a supportive organizational culture, protected time for antibiotic stewardship, and a cohesive organizational structure as facilitators of effective AMS [27]. These disparities in identified enablers across regions highlights the need for strategic implementation of ASPs with contextual considerations. Majority of the facilities involved in this study are still at the very preliminary stages of establishing ASPs in their facilities hence provide information on perceived facilitators. Nevertheless, the suggested facilitators corresponded to the essential elements identified by different guidelines for setting up and implementing AMS in hospital and out-patient setting in LMIC [12, 24, 28]. The different guidelines and tool kits have their peculiarity but with a common goal of providing strategic steps for implementation of AMS in healthcare settings.

Major themes that emerged as barriers to implementing ASP included inadequate personnel, legislation and policy, engaging the right focal persons and teamwork, multitasking and lack of data on AMR. These contextual issues would necessarily need to be addressed if we are to make meaningly progress as a nation in the antibiotic stewardship effort. A qualitative study to assess the feasibility of the WHO tool kit for AMS in LMIC identified lack of human and financial resources, inadequate regulations for prescription antibiotic sales, and insufficient AMS training as common barriers to implementation of ASP [29]. A few of the respondents indicated that practice-based reporting would be too burdensome and further lamented inadequate personnel as a barrier to proper implementation of stewardship strategies which would require collective and multidisciplinary effort. The respondents opined that in most cases, the available manpower is stretched thin and forced to multitask thereby hindering the likelihood of tracking of appropriate use of antibiotics in an accurate and fair manner. The majority of the respondents believed that the lack of adequate personnel to engage in AMS activities has contributed to several unqualified personnel engaging in antibiotics prescription without adequate training. Similar barriers have been identified by a systematic review of ASPs in developed and developing countries [30, 31]. On the contrary, a multi-country study identified “prohibitively expensive antimicrobials, limited antimicrobial availability, resistance to changing current practices regarding antimicrobial prescribing, and limited diagnostic capabilities” as barriers to improving antimicrobial prescribing [8].

The majority of the respondents agreed that antibiotic resistance is a major problem in Nigeria requiring urgent attention and should be prioritized and positioned at the political level with parliamentary approval. The need for AMS policy embedded in clinical governance and organizational investment in personnel had been identified in a previous study as crucial for a thriving ASP [30]. Nonetheless, successful institution and widespread implementation of ASP in healthcare facilities in Lagos State and Nigeria in general would require prescribers taking individual responsibility for their roles in the emergence or mitigation of AMR. Respondents were very receptive of ASP and willing to engage but they reasoned that implementation of AMS would require committed and dedicated personnel for effective strategic steps.

The respondents identified three themes for improving AMS in the country namely, stakeholder’s engagement, enhanced policies and regulation; and education. Majority strongly believed that if policies were set up from the micro level at the healthcare facilities, pharmacies to the macro level at the legislature and Federal Government sphere, illegal distribution, wrong prescriptions, and quack activities will be regulated. Furthermore, they opined that the relevant key stakeholders who had invested in AMS and understood how to navigate the terrain better should be involved in the decision and policy making process for effective outcomes. A study exploring factors influencing implementation of AMS across three low- and middle-income countries [Sri Lanka, Kenya, and Tanzania] recognized ‘Improved education and training’ as crucial for improving ASPs in tertiary care settings [8]. Education and training remain an integral part of the CDC recommended Core Elements of Hospital Antibiotic Stewardship Program [11]. The respondents reckoned that effective Antibiotics stewardship efforts should be paired with efforts aimed at educating prescribers about antibiotic resistance and antibiotic use. The respondents collectively agreed that holistic approach to awareness creation should target both prescribers and the patients accessing care. Educating the patients about AMR and how inappropriate antibiotic use drives resistance is crucial and will ultimately promote rational use of antibiotics among the public.

This study had some limitations. Study participation was restricted to only the prescribers attending the AMS workshop, hence may not be a true representative of prescribers in Lagos State. However, effort was made to include the different categories of healthcare facilities in Lagos i.e., primary, secondary, tertiary and private/faith-based healthcare facilities. Employing both quantitative and qualitative method of data collection enabled us to not only obtain information on the availability and level of ASP but also provided a deeper and more holistic understanding of the issues around implementation of ASP. The study did not employ in-depth interviews to gain individual perspective but rather utilized focus group discussions by gathering individual stakeholders for a collaborative discussion on issues around implementing ASPs in their various facilities. Respondents were vocal and understood the thematic focus and provided comprehensive discussions with demonstration of rich understanding of the study context. Majority of the facilities involved in this study (except for one) did not have a structured antimicrobial stewardship program, rather had stewardship teams operating at various levels. However, the respondents provided insight on their perceived facilitators and barriers to implementation of a standard stewardship program in their facilities. Most of the responses were context specific for resource poor setting. Despite using a mixed method, this study did not set out to determine facility specific differences in perceptions towards implementation of ASPs across the different healthcare facilities.

Conclusion

This study used a mixed method of quantitative and qualitative approach to explore perceptions and experiences, facilitators and barriers to AMS, and recommendations made to key stakeholders with the hope to implement them at various health facilities and pharmacies in Lagos. The study provides evidence-based recommendations to inform future interventional studies focused on implementing ASPs in health facilities throughout Lagos State. The results give insight into the prescribers’ perspective on the facilitators and barriers of AMS. Additionally, they shed light on the challenges faced and potential solutions for implementing ASPs in health facilities within Lagos State. Moreover, the study identified crucial contextual factors that should be addressed when developing ASPs in healthcare facilities across the country. These recommendations are even more crucial as the country prepares for the second phase of the National action plan (NAP 2.0) to tackle AMR. These findings provide a solid foundation for developing targeted and effective evidence-based strategies to enhance antimicrobial stewardship practices, ultimately promoting more responsible and sustainable use of antimicrobial agents.

Supporting information

S1 Checklist

(DOCX)

S1 Questionnaire

(PDF)

S1 File

(PDF)

S1 Data

(XLSX)

Acknowledgments

The authors wish to acknowledge the following persons: Olanrewaju Ishola, Kelechi Obiozor, Joy Jonah and Fredrick Fadunsin for their secretarial and technical assistance. We appreciate the prescribers who participated in the study and the healthcare facilities in Lagos State that nominated the workshop participants.

List of abbreviations

AMR

Antimicrobial resistance

AMS

Antimicrobial stewardship

AMU

Antimicrobial use

ASP

Antimicrobial stewardship program

CDC

Center for diseases control and prevention

COM-B

capability, opportunity, motivation and behavior

FGD

Focus Group Discussion

GLASS

Global antimicrobial resistance and use surveillance system

LMIC

Low- or Middle—Income Countries

NAP

National action plan

WHO

World Health Organization

Data Availability

All relevant data are within the manuscript and its Supporting Information files

Funding Statement

he author(s) received no specific funding for this work

References

  • 1.Lautenbach E, Weiner MG, Nachamkin I, Bilker WB, Sheridan A, Fishman NO. Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol. 2006. Sep;27(9):893–900. doi: 10.1086/507274 [DOI] [PubMed] [Google Scholar]
  • 2.Roberts MR. Realizing Societal Benefit from Academic Research: Analysis of the National Science Foundation’s Broader Impacts Criterion. Soc Epistemol. 2009. Jul 1;23(3–4):199–219. [Google Scholar]
  • 3.Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022. Feb 12;399(10325):629–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis Off Publ Infect Dis Soc Am. 2007. Jan 15;44(2):159–77. [DOI] [PubMed] [Google Scholar]
  • 5.Davey P, Peden C, Charani E, Marwick C, Michie S. Time for action—Improving the design and reporting of behaviour change interventions for antimicrobial stewardship in hospitals: Early findings from a systematic review. Int J Antimicrob Agents. 2015. Mar 1;45(3):203–12. doi: 10.1016/j.ijantimicag.2014.11.014 [DOI] [PubMed] [Google Scholar]
  • 6.Charani E, Edwards R, Sevdalis N, Alexandrou B, Sibley E, Mullett D, et al. Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review. Clin Infect Dis Off Publ Infect Dis Soc Am. 2011. Oct;53(7):651–62. doi: 10.1093/cid/cir445 [DOI] [PubMed] [Google Scholar]
  • 7.Hulscher MEJL, Grol RPTM, van der Meer JWM. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010. Mar;10(3):167–75. doi: 10.1016/S1473-3099(10)70027-X [DOI] [PubMed] [Google Scholar]
  • 8.Rolfe R, Kwobah C, Muro F, Ruwanpathirana A, Lyamuya F, Bodinayake C, et al. Barriers to implementing antimicrobial stewardship programs in three low- and middle-income country tertiary care settings: findings from a multi-site qualitative study. Antimicrob Resist Infect Control. 2021. Mar 25;10(1):60. doi: 10.1186/s13756-021-00929-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Global antimicrobial resistance and use surveillance system (‎GLASS)‎ report: 2022 [Internet]. [cited 2023 Aug 18]. Available from: https://www.who.int/publications-detail-redirect/9789240062702 [Google Scholar]
  • 10.Nigeria: National Action Plan for Antimicrobial Resistance [Internet]. [cited 2023 Aug 20]. Available from: https://www.who.int/publications/m/item/nigeria-national-action-plan-for-antimicrobial-resistance [Google Scholar]
  • 11.Fuller WL, Hamzat OT, Aboderin AO, Gahimbare L, Kapona O, Yahaya AA, et al. National action plan on antimicrobial resistance: An evaluation of implementation in the World Health Organization Africa region. J Public Health Afr. 2022. Jul 26;13(2):2000. doi: 10.4081/jphia.2022.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Core Elements of Hospital Antibiotic Stewardship Programs | Antibiotic Use | CDC [Internet]. 2022. [cited 2023 Jul 20]. Available from: https://www.cdc.gov/antibiotic-use/core-elements/hospital.html [Google Scholar]
  • 13.Core Elements of Antibiotic Stewardship for Nursing Homes | Antibiotic Use | CDC [Internet]. 2021. [cited 2023 Aug 20]. Available from: https://www.cdc.gov/antibiotic-use/core-elements/nursing-homes.html [Google Scholar]
  • 14.Chukwu EE, Oshun PO, Osuolale KA, Chuka-Ebene VO, Salako A, Idigbe IE, et al. Antimicrobial stewardship programmes in healthcare facilities in Lagos State, Nigeria: a needs assessment. J Glob Antimicrob Resist. 2021. Jun 1;25:162–70. doi: 10.1016/j.jgar.2021.02.034 [DOI] [PubMed] [Google Scholar]
  • 15.Björkman I, Berg J, Röing M, Erntell M, Lundborg CS. Perceptions among Swedish hospital physicians on prescribing of antibiotics and antibiotic resistance. Qual Saf Health Care. 2010. Dec;19(6):e8. doi: 10.1136/qshc.2008.029199 [DOI] [PubMed] [Google Scholar]
  • 16.Teixeira Rodrigues A, Roque F, Falcão A, Figueiras A, Herdeiro MT. Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies. Int J Antimicrob Agents. 2013. Mar;41(3):203–12. doi: 10.1016/j.ijantimicag.2012.09.003 [DOI] [PubMed] [Google Scholar]
  • 17.Understanding the Determinants of Antimicrobial Prescribing Within Hospitals: The Role of “Prescribing Etiquette” | Clinical Infectious Diseases | Oxford Academic [Internet]. [cited 2023 Aug 20]. Available from: https://academic.oup.com/cid/article/57/2/188/312770 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Team TNHSD. THE NATIONAL STRATEGIC HEALTH DEVELOPMENT PLAN FRAMEWORK (2009–2015) [Internet]. TWG- NSHDP/ HEALTH SECTOR DEVELOPMENT TEAM; 2009. [cited 2023 Aug 22]. Available from: http://ngfrepository.org.ng:8080/jspui/handle/123456789/3168 [Google Scholar]
  • 19.Zetts RM, Garcia AM, Doctor JN, Gerber JS, Linder JA, Hyun DY. Primary Care Physicians’ Attitudes and Perceptions Towards Antibiotic Resistance and Antibiotic Stewardship: A National Survey. Open Forum Infect Dis. 2020. Jul 1;7(7):ofaa244. doi: 10.1093/ofid/ofaa244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Skodvin B, Aase K, Charani E, Holmes A, Smith I. An antimicrobial stewardship program initiative: a qualitative study on prescribing practices among hospital doctors. Antimicrob Resist Infect Control. 2015. Jun 4;4(1):24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ploeg J, Davies B, Edwards N, Gifford W, Miller PE. Factors Influencing Best-Practice Guideline Implementation: Lessons Learned from Administrators, Nursing Staff, and Project Leaders. Worldviews Evid Based Nurs. 2007;4(4):210–9. doi: 10.1111/j.1741-6787.2007.00106.x [DOI] [PubMed] [Google Scholar]
  • 22.Michie S, van Stralen MM, West R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implement Sci. 2011. Apr 23;6(1):42. doi: 10.1186/1748-5908-6-42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hf H, Se S. Three approaches to qualitative content analysis. Qual Health Res [Internet]. 2005. Nov [cited 2023 Nov 9];15(9). Available from: https://pubmed.ncbi.nlm.nih.gov/16204405/ [DOI] [PubMed] [Google Scholar]
  • 24.Pollack LA, Plachouras D, Sinkowitz-Cochran R, Gruhler H, Monnet DL, Weber JT, et al. A Concise Set of Structure and Process Indicators to Assess and Compare Antimicrobial Stewardship Programs Among EU and US Hospitals: Results From a Multinational Expert Panel. Infect Control Hosp Epidemiol. 2016. Oct;37(10):1201–11. doi: 10.1017/ice.2016.115 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Iskandar K, Molinier L, Hallit S, Sartelli M, Hardcastle TC, Haque M, et al. Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture. Antimicrob Resist Infect Control. 2021. Mar 31;10(1):63. doi: 10.1186/s13756-021-00931-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Jeffs L, McIsaac W, Zahradnik M, Senthinathan A, Dresser L, McIntyre M, et al. Barriers and facilitators to the uptake of an antimicrobial stewardship program in primary care: A qualitative study. PLoS ONE [Internet]. 2020. [cited 2023 Nov 9];15(3). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059986/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Appaneal HJ, Luther MK, Timbrook TT, LaPlante KL, Dosa DM. Facilitators and Barriers to Antibiotic Stewardship: A Qualitative Study of Pharmacists’ Perspectives. Hosp Pharm. 2019. Aug 1;54(4):250–8. doi: 10.1177/0018578718781916 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.World Health Organization. Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit [Internet]. World Health Organization; 2019. [cited 2023 Jul 22]. 71 p. Available from: https://apps.who.int/iris/handle/10665/329404 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Maki G, Smith I, Paulin S, Kaljee L, Kasambara W, Mlotha J, et al. Feasibility Study of the World Health Organization Health Care Facility-Based Antimicrobial Stewardship Toolkit for Low- and Middle-Income Countries. Antibiotics. 2020. Sep;9(9):556. doi: 10.3390/antibiotics9090556 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gulik N van, Hutchinson A, Considine J, Driscoll A, Malathum K, Botti M. Barriers and facilitators to integrating antimicrobial stewardship into clinical governance and practice: A Thai case study. Int J Infect Control [Internet]. 2020. Jun 30 [cited 2023 Jul 19];16(2). Available from: https://ijic.info/article/view/19439 [Google Scholar]
  • 31.Rzewuska M, Duncan EM, Francis JJ, Morris AM, Suh KN, Davey PG, et al. Barriers and Facilitators to Implementation of Antibiotic Stewardship Programmes in Hospitals in Developed Countries: Insights From Transnational Studies. Front Sociol [Internet]. 2020. [cited 2023 Jul 19];5. Available from: https://www.frontiersin.org/articles/10.3389/fsoc.2020.00041 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Mabel Kamweli Aworh

24 Oct 2023

PONE-D-23-27149Implementation of antimicrobial stewardship programs: a study of prescribers’ perspective of facilitators and barriersPLOS ONE

Dear Dr. Chukwu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 08 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 

4. Please upload a copy of Supporting Information Figure/Table/etc. Supplementary material (Suppl 1&2) which you refer to in your text on page 4.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1. General comment: This topic is key in the fight against AMR and the authors are commended for the efforts. However, I strongly suggest that the authors read through the entire manuscript for corrections of some grammatical errors.

2. Abstract

a. In the methods, I suggest you use “focus group discussion” instead of “focused group discussion”.

b. In the methods, no clear details on the analysis of the quantitative data.

c. In the results, you may write “thirty” or “30” instead of “thirty (30)”.

d. Regarding the means, having stated the mean and standard deviation, there may be no need to still state the range. Range is used as the measure of dispersion for skewed data while standard deviation is used as the measure of dispersion for data with normal distribution.

e. The use of AMS in the results was not defined. The authors may have to write it out in full as was done in the conclusion.

f. Having defined ASPs, there should be consistency in its use rather than writing in full as seen in the last sentence of the conclusion.

3. Introduction

a. Define AMR in its first use before continuing with the abbreviation.

b. Having defined ASPs, there should be consistency in its use rather than writing in full again.

c. In page 3, LMICs should be stated in the first paragraph before its continuous use.

4. Methods

a. In the methods, I suggest you use “focus group discussion” instead of “focused group discussion”.

b. Under the “Study Design and Sampling Technique”, some details on the analysis of the qualitative data should be moved to the data analysis subsection of the methods.

c. The authors stated in the results section that 20 participants were interviewed for the qualitative component of the study. Were these key informant interviews or FGDs? If they were FGDs, how many FGDs were conducted and what was the number of participants per FGD? Or were all 20 participants included in one FGD?

5. Results

a. Take note of 2c and 2d above.

b. The results should be reported in past tense. See example from the results section - “About one-half of the participants either do not have or are not sure if there exists an antimicrobial stewardship team in their facility while 28% were members of their facility stewardship team”

6. Discussion

a. The authors made a good attempt to discuss their results.

7. References

a. About half of the references are more than 5 years old. I recommend that the authors add more recent references (within the last 5 years).

Reviewer #2: This work is so important, particularly as Nigeria is implementing NAP. The study will make a great contribution. However, there are issues that need to be considered and are highlighted below. There are valuable questions about the methods and results that need to be addressed to give this readers that insight that is required for this valuable study.

Abstract…… programs and interventions in one sentence side-by-side

…..creating awareness and training and inadequate personnel respectively “not clear”. OBSERVE PUNCTUATION MARKS. Which are the facilitators, and which are the barriers. That needs to clearly come out in your abstract.

……”resource-poor” and not resource poor

Introduction

….”emergence and transmission of AMR in Nigeria” change to “transmission of AMR genes among disease pathogens”. Antimicrobial resistance doesn’t seem to be transmitted. It’s the genes that are the problem.

Change ….”low-and-middle” to ….”low- and middle-income….” That isn’t one word

Methods….

…..”antibiotic- related” change to antibiotic-related

….”faith- based” change to faith-based

What ethical issues could be anticipated from this study and how were these issues addressed?

How many FGDs were conducted and do the authors think the number of FGDs were sufficient?

How about conducting In-depth interviews with these stakeholders? Could that had given better perspective to this study?

What software was used for the qualitative coding and analysis?

……”SPSS version 26.0For…..” Change to ………….SPSS version 26.0. For………….

Results

……”About one-half”……..Correct to “About half” Is there anything like two-half???

68% is about two-third and not about one-half, kindly correct!!!

What the authors described as facilitators are suggested approaches to improve AMS rather than facilitators!! Correct the title to reflect appropriately what is reflected by the results!!

The entire barrier section has not supporting quotes! Why??

What is the difference between the recommended strategies and facilitators as captured in the study??

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Comments for review AMS paper.docx

PLoS One. 2024 Jan 19;19(1):e0297472. doi: 10.1371/journal.pone.0297472.r002

Author response to Decision Letter 0


9 Nov 2023

Reviewer #1

S/N Reviewer’s comments Authors response

1 General comment: This topic is key in the fight against AMR and the authors are commended for the efforts. However, I strongly suggest that the authors read through the entire manuscript for corrections of some grammatical errors. Thank you for taking time out to review our manuscript.

The authors have read through the manuscript and corrected grammatical errors

2 Abstract

a. In the methods, I suggest you use “focus group discussion” instead of “focused group discussion”.

b. In the methods, no clear details on the analysis of the quantitative data.

c. In the results, you may write “thirty” or “30” instead of “thirty (30)”.

d. Regarding the means, having stated the mean and standard deviation, there may be no need to still state the range. Range is used as the measure of dispersion for skewed data while standard deviation is used as the measure of dispersion for data with normal distribution.

e. The use of AMS in the results was not defined. The authors may have to write it out in full as was done in the conclusion.

f. Having defined ASPs, there should be consistency in its use rather than writing in full as seen in the last sentence of the conclusion.

Done!

A statement of the quantitative data analysis approach used has been added.

Corrected

This has been corrected as mean and standard deviation.

This has now been written in full at its first appearance.

Done!

3 3. Introduction

a. Define AMR in its first use before continuing with the abbreviation.

b. Having defined ASPs, there should be consistency in its use rather than writing in full again.

c. In page 3, LMICs should be stated in the first paragraph before its continuous use.

Done

Done

Done

4 4. Methods

a. In the methods, I suggest you use “focus group discussion” instead of “focused group discussion”.

b. Under the “Study Design and Sampling Technique”, some details on the analysis of the qualitative data should be moved to the data analysis subsection of the methods.

c. The authors stated in the results section that 20 participants were interviewed for the qualitative component of the study. Were these key informant interviews or FGDs? If they were FGDs, how many FGDs were conducted and what was the number of participants per FGD? Or

were all 20 participants included in one FGD?

Corrected

The analysis details have been moved to the data analysis section.

20 participants volunteered and participated in the focus group discussions. Two FDGs were conducted comprising of 10 participants each. This has been clarified

5 5. Results

a. Take note of 2c and 2d above.

b. The results should be reported in past tense. See example from the results section - “About one-half of the participants either do not have or are not sure if there exists an antimicrobial stewardship team in their facility while 28% were members of their facility stewardship team”

Done

Done

6 6. Discussion

a. The authors made a good attempt to discuss their results.

Thank you

7 7. References

a. About half of the references are more than 5 years old. I recommend that the authors add more recent references (within the last 5 years). Some more recent references have been added

Reviewer #2: This work is so important, particularly as Nigeria is implementing NAP. The study will make a great contribution. However, there are issues that need to be considered and are highlighted below. There are valuable questions about the methods and results that need to be addressed to give these readers that insight that is required for this valuable study.

S/N Reviewer’s comments Authors response

1 Abstract…… programs and interventions in one sentence side-by-side

…..creating awareness and training and inadequate personnel respectively “not clear”. OBSERVE PUNCTUATION MARKS. Which are the facilitators, and which are the barriers. That needs to clearly come out in your abstract.

……”resource-poor” and not resource poor

Done.

This has been rephrased for clarity.

Done

2 Introduction

….”emergence and transmission of AMR in Nigeria” change to “transmission of AMR genes among disease pathogens”. Antimicrobial resistance doesn’t seem to be transmitted. It’s the genes that are the problem.

Change ….”low-and-middle” to ….”low- and middle-income….” That isn’t one word

Done

Done

3 Methods….

…..”antibiotic- related” change to antibiotic-related

….”faith- based” change to faith-based

What ethical issues could be anticipated from this study and how were these issues addressed?

How many FGDs were conducted and do the authors think the number of FGDs were sufficient?

How about conducting In-depth interviews with these stakeholders? Could that had given better perspective to this study?

What software was used for the qualitative coding and analysis?

……”SPSS version 26.0For…..” Change to ………….SPSS version 26.0. For………….

Done

Done

Ethical clearance for human subject participation to conduct this study was obtained from the NIMR Institutional Review Board. However, participants were informed of their right to either participate or decline to participate in the study and only participants who gave their informed consent by signing the written consent form were included in the study.

Two sets of FGDs were conducted with 10 participants in each set. One set was conducted with medical doctors and another set was conducted with pharmacists. Participation in the FGDs was voluntary. The FGDs had proper representation of participants based on demographics (Gender, age,) type of practice (public, private), range of experiences (early career, mid-career and advanced career clinicians and pharmacists) and the numbers of specialist in each group (10) providing unique and vast knowledge. The FGDs ended when the participants did not provide new or additional data as the same thematic areas were being re-emphasized and re-explained.

This information has been included in the methods section (Focus Group Discussion)

FGDs and In-depth interviews both offer unique advantages for qualitative research. However, for the purpose of this study, we aimed to gather individual stakeholders for a collaborative discussion on issues around implementing ASPs rather than individual perspective.

In addition, participants were vocal, and understood the thematic focus and provided comprehensive discussions, rich understanding of the study context.

Data analysis was done manually by a team of qualitative research experts and the processes has been explained in the data analysis section.

Done

4 Results

……”About one-half”……..Correct to “About half” Is there anything like two-half???

68% is about two-third and not about one-half, kindly correct!!!

What the authors described as facilitators are suggested approaches to improve AMS rather than facilitators!! Correct the title to reflect appropriately what is reflected by the results!!

The entire barrier section has not supporting quotes! Why??

What is the difference between the recommended strategies and facilitators as captured in the study??

Done

Thank you, the participants responded based on the question asked about factors that could facilitate antimicrobial stewardship. The response documented were the first-hand accounts of what they believed were the factors that will motivate prescribers and healthcare facilities to engage in antimicrobial stewardship. However, we recognize that some participant-identified facilitators also featured/doubled as recommendations hence the implicated themes have now been moved to and discussed under recommendations.

Supporting quotes have been added to this section.

The respondents provided insights on the facilitators of AMS which are factors that the respondents believed would favour, motivate, or help individual prescribers as well as healthcare facilities to engage in a rational prescription of antibiotics while also recommending approaches for effective ASP implementation.

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Mabel Kamweli Aworh

29 Nov 2023

PONE-D-23-27149R1Implementation of antimicrobial stewardship programs: a study of prescribers’ perspective of facilitators and barriersPLOS ONE

Dear Dr. Chukwu,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 13 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

In response to the reviewer's comments kindly address the following issues;

1. Please provide additional quotes for facilitators of AMS. For each of the points raised, kindly provide at least two quotes from the FGD. Only one point "Having specialized and dedicated Teams" was supported by one quote.

2. Also provide at least two quotes for each barrier to the uptake of stewardship programs as provided by the respondents during the FGD.  As it currently stands each point has one supporting quote. Kindly provide one additional quote to the one already provided for clarity and consistency please.

3. Once an acronym/abbreviation has been defined upon it's first use, it is expected that you use the acronym in the rest of the manuscript. For instance AMR has been defined previously so kindly correct page 22 line 3 "lack of data on antimicrobial resistance" to "lack of data on AMR". Please fix this issue wherever it occurs in the manuscript. Also check for consistency with other abbreviations used. This applies to AMS and antimicrobial stewardship. So kindly fix this as well all through the manuscript. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: I still don't understand the reason for leaving out the quotes for some of the facilitation.

The author(s) did not adequately address the issue of barriers. I have stated that the barriers identified by the author(s) did not align with the quotes and read more like suggestions to improvement.

Again, I am wondering if the framework was used to develop a discussion guide because if you begin to ask questions until respondents began to repeat their responses then I wonder of there wad and FGD guide and if it was followed.

Why did the authors decide to leave recommendations in table and the others in full writing?

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jan 19;19(1):e0297472. doi: 10.1371/journal.pone.0297472.r004

Author response to Decision Letter 1


22 Dec 2023

S/N Editorial comments Author’s response

1.

Please provide additional quotes for facilitators of AMS. For each of the points raised, kindly provide at least two quotes from the FGD. Only one point "Having specialized and dedicated Teams" was supported by one quote.

Additional quotes have been provided for the facilitators with at least two quotes per listed facilitator

Also provide at least two quotes for each barrier to the uptake of stewardship programs as provided by the respondents during the FGD. As it currently stands each point has one supporting quote. Kindly provide one additional quote to the one already provided for clarity and consistency please. One additional quote has been provided for the barriers with at least two quotes per listed barrier

Once an acronym/abbreviation has been defined upon it's first use, it is expected that you use the acronym in the rest of the manuscript. For instance AMR has been defined previously so kindly correct page 22 line 3 "lack of data on antimicrobial resistance" to "lack of data on AMR". Please fix this issue wherever it occurs in the manuscript. Also check for consistency with other abbreviations used. This applies to AMS and antimicrobial stewardship. So kindly fix this as well all through the manuscript. Done!

The defined terms have been replaced with acronyms all through the manuscript.

Reviewer #2: . Thank you for your review comments

I still don't understand the reason for leaving out the quotes for some of the facilitation Quotes have been provided for all the facilitators and barrier initially without quotes and additional quotes added to the existing with a target of two quotes per listed factor

The author(s) did not adequately address the issue of barriers. I have stated that the barriers identified by the author(s) did not align with the quotes and read more like suggestions to improvement. The authors presented respondents identified barriers and perceived challenges to the effective implementation of ASP in their various facilities which was summarized under 5 themes. We have added additional quotes to provide more context to their stated barriers.

We also want to mention that majority of the facilities (except one facility) did not have a standard antimicrobial stewardship program, rather had stewardship teams operating at various levels and the respondents discussed their perceived facilitators and barriers to implementation of a stewardship program in their facilities. Most of the responses were context specific for a resource poor setting. This has been stated in the limitation section

Again, I am wondering if the framework was used to develop a discussion guide because if you begin to ask questions until respondents began to repeat their responses then I wonder of there wad and FGD guide and if it was followed. The FDG was conducted using a semi-structured interview guide which is provided as a supplementary material (S2) with probes to allow flexibility for the respondents provide in-depth insight on emerging themes and sub-themes and also exploring new ideas with follow-up questions until no new information is being provided

Why did the authors decide to leave recommendations in table and the others in full writing? The Use of tables for the recommendations allowed for a more detailed presentation of the identified themes and sub-themes and their supporting quotes

However, the implication of all identified facilitators and barriers as well as recommendations were further discussed in context and in comparison, with the quantitative data in the discussion session

Attachment

Submitted filename: Response to reviewers comments_2nd revision.docx

Decision Letter 2

Mabel Kamweli Aworh

8 Jan 2024

Implementation of antimicrobial stewardship programs: a study of prescribers’ perspective of facilitators and barriers

PONE-D-23-27149R2

Dear Dr. Chukwu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Mabel Kamweli Aworh, DVM, MPH, PhD. FCVSN

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: The manuscript looks good but with only one recommendation. "Facilitators" should be changed to "potential facilitators" because they would be facilitators if they are implemented but currently, they are not based on the responses and quotes that are presented at the moment.

The authors need to review the manuscript in accordance with the PLOS ONE guidelines and then it will be good.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Mabel Kamweli Aworh

11 Jan 2024

PONE-D-23-27149R2

PLOS ONE

Dear Dr. Chukwu,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Mabel Kamweli Aworh

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist

    (DOCX)

    S1 Questionnaire

    (PDF)

    S1 File

    (PDF)

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: Comments for review AMS paper.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Response to reviewers comments_2nd revision.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES